A Global Movement of Hope: Clubhouse International's Mental Health Advocacy Initiative 2025
Advocacy efforts have become more essential and urgent as mental health challenges sweep through continents. These issues are global concerns, as seen from the silent crises in underserved communities to the growing sense of disconnection in wealthier nations. Clubhouse International, a forward-thinking New York-based nonprofit organization, believes collaborative, sustained, and compassionate responses are needed. Hence, it creates platforms rooted in dignity, purpose, and above all, hope.
Established in 1994 with roots in 1948, Clubhouse International has been known for empowering individuals living with mental illness to reclaim their lives through community and connection. Employing the Clubhouse Model, the organization provides safe, inclusive environments where members receive support to build meaningful relationships, pursue education, obtain employment, and access housing and healthcare.
Clubhouse International recognizes how systemic issues affecting mental health care are becoming more severe amid growing uncertainty. Because of the complex landscape, its local Clubhouses are facing challenges that might leave vulnerable populations without access to essential services. This crisis mirrors the global truth that mental health support structures are usually low in priority, making it one of the first to face financial shortfalls despite being integral to societal well-being.
The stigma surrounding mental illness also continues to hinder progress. Clubhouse International offers a vision that shifts away from an underfunded, misunderstood, and invisible landscape. It champions mutual respect and shared humanity. Anna Sackett Rountree, Director of Communications for Clubhouse International, notes: 'Local leaders and global collaboration is needed to address these challenges. We can't afford to silo our solutions when the need is so universal.'
This spirit of innovation and collaboration on a local and global scale comes alive in Clubhouse International's advocacy work, especially during Mental Health Awareness Month in May. This year, the organization is leading multiple initiatives aiming to raise awareness, inspire action, and systemic change.
Its Clubhouse Giving Day, a global day of fundraising and solidarity, is one of these innovative initiatives. This annual campaign mobilizes the Clubhouse community globally to celebrate the impact of the Clubhouse Model. The individual donations, community fundraisers, and widespread social media engagement made possible during this day are essential in sustaining and extending the reach of Clubhouses worldwide. Every dollar raised contributes to expanding access, supporting new Clubhouse development, and changing lives by providing opportunities for employment, education, and friendship to those usually left behind.
The Clubhouse International World Seminar complements these efforts. This five-day conference is a vibrant forum for knowledge exchange, inspiration, and strategy-building. Here, 700 participants from different U.S. states and countries share best practices, new innovations, and success stories. Topics can be anything enlightening, from strengthening employment programs and community partnerships to exploring governance, inclusion, and wellness.
For this year's World Seminar, guest speakers include Seth Kahan, founder and CEO of Visionary Leadership, and Andrej Vrsansky, President at Mental Health Europe and CEO at the League for Mental Health in Slovakia. They will offer insights that can help participants envision a future where mental health systems are holistic, person-centered, and built around recovery.
In tandem with these global efforts, Clubhouse International also focuses on strategic, local engagement through the US Clubhouse Advocacy Week of Action. This initiative invites Clubhouses across the country to host open houses, welcome policymakers, and share stories that highlight the model's impact. 'Last year, 40 Clubhouses across 18 states and Washington, DC, participated,' shares Rountree. 'We showed lawmakers how impactful Clubhouses can be when it comes to mental health recovery and how adopting policies supporting psychosocial rehabilitation and sustained funding can make a sustainable difference for individuals and communities.
The nonprofit is a founder and participant of Mental Health Action Day, powered by MTV, which encourages individuals and institutions to improve mental health awareness and access. It calls people to get involved, share their stories, and advocate for change in their communities.
All these initiatives embody Clubhouse International's philosophy that solutions must be informed by real-world needs, the voice of lived experience, cultural context, and best practices. Moreover, they capture the organization's core belief that mental health is a universal human right and recovery must be available to everyone in all communities worldwide.
Clubhouse International emphasizes that change is happening, but it can't continue in isolation. The future of mental health care depends on collective action and bold advocacy.
For Clubhouse International, every Clubhouse is a lifeline. Every voice in support is part of the solution. Lastly, every contribution fuels a global movement that brings people in from the margins and places them at the center of community and care.
Media Contact
Name: Anna Sackett Rountree
Email: [email protected]
Source published by Submit Press Release >> A Global Movement of Hope: Clubhouse International's Mental Health Advocacy Initiative 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
UnitedHealth (UNH) Board Approves Quarterly Dividend
UnitedHealth Group Incorporated (NYSE:UNH) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 13, UnitedHealth Group Incorporated (NYSE:UNH) announced that its board of directors declared a cash dividend of $2.21 per share. This dividend will be paid on September 23, 2025, to all common stock shareholders of record as of the close of business on September 15, 2025. Previously, in June 2025, UnitedHealth Group Incorporated (NYSE:UNH) raised its quarterly dividend rate by 5% to $2.21. Ken Wolter/ During the second quarter of 2025, UnitedHealth Group Incorporated (NYSE:UNH) returned $4.5 billion to shareholders in the form of dividends and share repurchases. The company's annualized return on equity for the first half of 2025 was 20.6% UnitedHealth Group Incorporated (NYSE:UNH) is an American health insurance and healthcare services company. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey.
Business Upturn
5 hours ago
- Business Upturn
Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection
Dr. Lal PathLabs has taken a groundbreaking step in advancing cancer diagnostics in India by becoming the first laboratory in the country to introduce a deep learning-based AI module for the detection of lymph node metastasis, including micrometastasis. This innovation, developed in collaboration with Singapore-based healthtech company Qritive, was recently showcased at USCAP 2025, one of the most prestigious pathology conferences in the world. The accurate detection of cancer spread to lymph nodes is a critical factor in determining the stage and treatment strategy for patients. Missing these signs of cancer progression can allow the disease to advance, increasing the chances of it spreading to distant organs and reducing survival rates. The ability to identify even occult metastases in patients with early-stage cancer has the potential to significantly influence treatment plans and improve outcomes. Traditionally, detecting micrometastases—small clusters of cancer cells hidden in lymph nodes—has been a time-consuming and complex process, often requiring advanced testing. The new AI system, called QiAI Lymph Node Dx, addresses this challenge by using deep learning to analyze digital slides and identify cancer cells with exceptional precision. This integration of AI into diagnostic practice ensures that cancer detection becomes faster, more reliable, and highly accurate. What makes this development especially impactful is its ability to pick up even single cancer cells, which were later validated through immunohistochemistry testing. The AI model has been tested across various cancer types, including breast, colon, stomach, and esophageal cancers, consistently delivering highly accurate results. Breast cancer, which accounts for nearly 28% of cancer cases among women in India, particularly stands to benefit from this breakthrough, highlighting the clinical relevance of the technology. By achieving complete sensitivity and negative predictive value—meaning no metastatic cases went undetected—the AI system has proven to be a robust screening tool. Its tumor-agnostic design allows it to function effectively across different cancer types, making it a versatile solution for oncologists and pathologists alike. As cancer incidence continues to rise in India, the integration of advanced AI-powered diagnostic tools such as QiAI Lymph Node Dx is set to transform the landscape of cancer care. By enabling earlier and more accurate diagnoses, this technology not only improves the efficiency of medical practice but also ensures better treatment decisions, offering renewed hope to patients battling cancer. Ahmedabad Plane Crash
6 hours ago
New malaria drug for babies offers hope to health workers in Uganda
KAMPALA, Uganda -- Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.' Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds). Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than 5 and pregnant women, according to WHO. Nigeria, Congo and Uganda — in that order — are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitizing the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centers across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria.' In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the U.S. shrank its foreign aid program earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under 5 years,' she said. ___
